The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience (original) (raw)
References
Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE (2014) Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 32(8):774–782. https://doi.org/10.1200/jco.2013.51.8886 ArticlePubMedPubMed Central Google Scholar
Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg 117(5):851–859. https://doi.org/10.3171/2012.8.Jns12234 ArticlePubMed Google Scholar
Gessler F, Forster MT, Duetzmann S, Mittelbronn M, Hattingen E, Franz K, Seifert V, Senft C (2015) Combination of intraoperative magnetic resonance imaging and intraoperative fluorescence to enhance the resection of contrast enhancing gliomas. Neurosurgery 77(1):16–22. https://doi.org/10.1227/neu.0000000000000729 (Discussion 22) ArticlePubMed Google Scholar
Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C (2018) Intraoperative imaging technology to maximise extent of resection for glioma. The Cochrane database of systematic reviews. 1:Cd012788. https://doi.org/10.1002/14651858.CD012788.pub2
Kittle D, Mamelak A, Parrish-Novak J, Hansen S, Patil R, Wadhone-Gangalum P, Ljubimova J, Black KL, Butte P (2014) Fluorescence-guided tumor visualization using the tumor paint BLZ-100. Cureus. https://doi.org/10.7759/cureus.210 Article Google Scholar
Prada F, Bene MD, Fornaro R, Vetrano IG, Martegani A, Aiani L, Sconfienza LM, Mauri G, Solbiati L, Pollo B, DiMeco F (2016) Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurg Focus 40(3):E7. https://doi.org/10.3171/2015.11.Focus15573 ArticlePubMed Google Scholar
Yamada S, Muragaki Y, Maruyama T, Komori T, Okada Y (2015) Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas. Clin Neurol Neurosurg 130:134–139. https://doi.org/10.1016/j.clineuro.2015.01.005 ArticlePubMed Google Scholar
Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J (2014) Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 36(2):E10. https://doi.org/10.3171/2013.12.Focus13464 ArticlePubMed Google Scholar
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401. https://doi.org/10.1016/s1470-2045(06)70665-9 ArticleCASPubMed Google Scholar
Roder C, Bisdas S, Ebner FH, Honegger J, Naegele T, Ernemann U, Tatagiba M (2014) Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Eur J Surg Oncol 40(3):297–304. https://doi.org/10.1016/j.ejso.2013.11.022 ArticleCASPubMed Google Scholar
Della Puppa A, Ciccarino P, Lombardi G, Rolma G, Cecchin D, Rossetto M (2014) 5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns. BioMed Res Int 2014:232561. https://doi.org/10.1155/2014/232561 ArticleCASPubMed Google Scholar
Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M (2011) Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosur 76(1–2):120–127. https://doi.org/10.1016/j.wneu.2011.02.005 Article Google Scholar
Cozzens JW, Lokaitis BC, Moore BE, Amin DV, Espinosa JA, MacGregor M, Michael AP, Jones BA (2017) A phase 1 dose-escalation study of oral 5-aminolevulinic acid in adult patients undergoing resection of a newly diagnosed or recurrent high-grade glioma. Neurosurgery 81(1):46–55. https://doi.org/10.1093/neuros/nyw182 ArticlePubMed Google Scholar
Stummer W, Stepp H, Wiestler OD, Pichlmeier U (2017) Randomized, prospective double-blinded study comparing 3 different doses of 5-aminolevulinic acid for fluorescence-guided resections of malignant gliomas. Neurosurgery 81(2):230–239. https://doi.org/10.1093/neuros/nyx074 ArticlePubMedPubMed Central Google Scholar
Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102(1):105–113. https://doi.org/10.1007/s11060-010-0296-4 ArticleCASPubMed Google Scholar
Roberts DW, Valdes PA, Harris BT, Fontaine KM, Hartov A, Fan X, Ji S, Lollis SS, Pogue BW, Leblond F, Tosteson TD, Wilson BC, Paulsen KD (2011) Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 114(3):595–603. https://doi.org/10.3171/2010.2.Jns091322 ArticlePubMed Google Scholar